Company: IMRX
Filing Date: 2025-09-03
Form Type: S-3
Source: 0001104659-25-086561
Chunk: 42

Company: Immuneering Corp
Filing Date: 2025-09-03
Form: S-3
Chunk 42
---
 the registrant in the capacities and on the dates indicated.

| ​ 
 ​ 
 ​ | SIGNATURE                  
 /s/ Benjamin J. Zeskind    
 ​                          
 Benjamin J. Zeskind, Ph.D. 
 /s/ Mallory Morales        
 ​                          
 Mallory Morales            | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | TITLE                                                                              
 President, Chief Executive Officer and Director (Principal ExecutiveOfficer)       
 Chief Accounting Officer andTreasurer (Principal Financial and Accounting Officer) | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | DATE              
 September 2, 2025 
 September 2, 2025 | ​ 
 ​ 
 ​ |
|:--|:---------------------------|:--|:--|:-----------------------------------------------------------------------------------|:--|:--|:------------------|:--|
| ​ | /s/ Robert J. Carpenter    
 ​                          
 Robert J. Carpenter        | ​ | ​ | Director                                                                           | ​ | ​ | September 2, 2025 | ​ |
| ​ | /s/ Peter Feinberg         
 ​                          
 Peter Feinberg             | ​ | ​ | Director                                                                           | ​ | ​ | September 2, 2025 | ​ |
| ​ | /s/ Diana F. Hausman       
 ​                          
 Diana F. Hausman, M.D.     | ​ | ​ | Director                                                                           | ​ | ​ | September 2, 2025 | ​ |
| ​ | /s/ Laurie B. Keating      
 ​                          
 Laurie B. Keating          | ​ | ​ | Director                                                                           | ​ | ​ | September 2, 2025 | ​ |
| ​ | /s/ Thomas J. Schall       
 ​                          
 Thomas J. Schall           | ​ | ​ | Director                                                                           | ​ | ​ | September 2, 2025 | ​ |

II-7